EDGAR Filing Documents for 0001493152-18-013580

Form 8-K - Current report:

SEC Accession No. 0001493152-18-013580

Filing Date

2018-09-21

Accepted

2018-09-21 16:05:31

Documents

Period of Report

2018-09-18

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm	8-K	78688
2		ex2-1.htm	EX-2.1	857112
3		ex10-1.htm	EX-10.1	321878
4		ex10-2.htm	EX-10.2	15567
5		ex10-3.htm	EX-10.3	95429
6		ex99-1.htm	EX-99.1	88404
7		ex99-2.htm	EX-99.2	89653
8		ex99-3.htm	EX-99.3	17352
9		ex99-4.htm	EX-99.4	3244
10		ex99-4_001.jpg	GRAPHIC	128834
11		ex99-4_002.jpg	GRAPHIC	408206
12		ex99-4_003.jpg	GRAPHIC	247405
	Complete submission text file	0001493152-18-013580.txt		2649581

Mailing Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070

Business Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070 201.528.9200

CANCER GENETICS, INC (Filer) CIK: 0001349929 (see all company filings)